Magnetic resonance imaging as a screening procedure for methotrexate induced liver damage
- 31 August 1987
- journal article
- research article
- Published by Oxford University Press (OUP) in British Journal of Dermatology
- Vol. 117 (3) , 311-316
- https://doi.org/10.1111/j.1365-2133.1987.tb04137.x
Abstract
Spin lattice relaxation time (TI) measured with a low field strength magnetic resonance imager in 51 patients with severe psoriasis did not correlate with the histological findings of liver biopsies taken during treatment with oral methotrexate. Liver TI measurement at low magnetic field is of no valueas a screening procedure in monitoring methotrexate induced liver damage.Keywords
This publication has 11 references indexed in Scilit:
- Monoclonal antibodies against epidermal cell surface and dermal-epidermal junction: antigens which may be epidermal cell spreading factorsBritish Journal of Dermatology, 1986
- Ultrasound as a screening procedure for methotrexate-induced hepatic damage in severe psoriasisBritish Journal of Dermatology, 1985
- Methotrexate maintenance therapy and liver damage in psoriasisClinical and Experimental Dermatology, 1985
- Nuclear Magnetic Resonance Proton ImagingPublished by Springer Nature ,1984
- Liver ultrasound—a safe screening test for methotrexate patientsBritish Journal of Dermatology, 1983
- Liver biopsies upsilon liver scans in methotrexate-treated patients with psoriasisArchives of Dermatology, 1982
- Methotrexate guidelines—revisedJournal of the American Academy of Dermatology, 1982
- Methotrexate hepatotoxicity in psoriasis. Consideration of liver biopsies at regular intervalsArchives of Dermatology, 1980
- Psoriasis-liver-methotrexate interactionsArchives of Dermatology, 1973
- Methotrexate Hepatotoxicity in Psoriasis--Comparison of Different Dose RegimensBMJ, 1972